2,3-Dichloro-6-methylquinoxaline - CAS 39267-05-5
Catalog: |
BB023923 |
Product Name: |
2,3-Dichloro-6-methylquinoxaline |
CAS: |
39267-05-5 |
Synonyms: |
2,3-dichloro-6-methylquinoxaline |
IUPAC Name: | 2,3-dichloro-6-methylquinoxaline |
Description: | 2,3-Dichloro-6-methylquinoxaline (CAS# 39267-05-5) is a useful research chemical. |
Molecular Weight: | 213.06 |
Molecular Formula: | C9H6Cl2N2 |
Canonical SMILES: | CC1=CC2=C(C=C1)N=C(C(=N2)Cl)Cl |
InChI: | InChI=1S/C9H6Cl2N2/c1-5-2-3-6-7(4-5)13-9(11)8(10)12-6/h2-4H,1H3 |
InChI Key: | UWSAFTDEEVGSAC-UHFFFAOYSA-N |
Boiling Point: | 289.1 °C at 760 mmHg |
Density: | 1.418 g/cm3 |
MDL: | MFCD00270819 |
LogP: | 3.24500 |
GHS Hazard Statement: | H302 (97.44%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P305+P351+P338, P310, P330, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
KR-102070265-B1 | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
KR-20180089298-A | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
US-2020039984-A1 | Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient | 20170126 |
WO-2018139876-A1 | Novel [1,2,4]triazolo[4, 3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating bet protein-related diseases, containing same as active ingredient | 20170126 |
US-11028090-B2 | [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient | 20170126 |
Complexity: | 189 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 211.9908036 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 211.9908036 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS